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Introduction 
Facial paralysis causes significant functional and psychological morbidity, including anxiety and 
depression [1].  The muscles of facial expression play a critical role in protecting the eye, maintaining 
oral competence, and are essential for portraying emotions to facilitate social interaction.  The 
management of patients with facial palsy can be challenging because there are over 50 aetiologies 
that can result in facial muscle paralysis and measuring severity is challenging.  Facial palsy 
encountered in primary care can fall into one of three broad groups that help guide the 
management in both primary and secondary care.  These are acute flaccid facial paralysis (AFFP); 
long-standing flaccid facial paralysis (LFFP) and post-paralytic facial palsy (PPFP) [2].  This article aims 
to provide guidance on when and why to refer patients with facial palsy to secondary care. 
 
Acute flaccid facial paralysis: 
The critical distinction between AFFP and LFFP relates to the presence or absence of viable facial 
mimetic muscles.   The exact time at which the facial muscles become non-receptive to re-
innervation remains unknown, however, many would consider 12 months as the point a patient 
would transfer into the LFFP group [3].   
 
The majority of patients with AFFP will have Bell’s palsy [4].  The exact cause of Bell’s palsy is 
unknown, but it is thought to result from facial nerve swelling within the confines of the temporal 
bone.  Eye care with lubricants and night-time taping is essential and, in those presenting within 72 
hours, commencing a 10-day course of 50mg prednisolone is the only treatment shown to improve 
the long-term outcome [4,5].  Amongst those with Bell’s palsy, 83% will go on to fully recover facial 
movement if treated with prednisolone with most showing improvement from three weeks 
onwards. Only 72% make a full recovery if not treated with steroids within 72hours [5]. The 
remainder will have some degree of long-term sequelae and fall into the LFFP or PPFP groups.  Table 
1 describes the timeframe and indication for referral amongst those with AFFP. 
 
Careful clinical assessment for a painful vesicular rash in or around the ear, mouth or scalp should 
alert the physician to the diagnosis of Ramsay Hunt Syndrome where the addition of acyclovir to the 
course of steroids is necessary.  Slow onset paralysis, involvement of other nerves (e.g. hearing or 
taste) should alert the clinician that skull base or parotid tumours are possible causes and warrant 
prompt investigation.   
 
In those who do not have a complete return of facial movement after 3 months, several non-surgical 
and surgical treatment options can be provided through specialised facial palsy centres to improve 
long-term function and appearance.  The ultimate objective is to restore movement within the 
patient’s native facial muscles, as transfer of muscles from other areas of the body can never 
accurately replicate the complex, synchronised movement of the facial mimetic muscles. To achieve 
this, intervention at around 6 months should be the target in those unlikely to spontaneously 
recover facial movements. 
 
Long-standing flaccid facial paralysis: 
This group consists of those with both congenital and acquired causes of facial palsy persisting more 
than 12 months.  Most will have established an ocular care regimen, but this should be checked at 
each clinical review.  Amongst patients born with facial paralysis, early referral to the local paediatric 
service is essential to assess for potential causes of the facial palsy.  Although unlikely, it should be 
checked that those with LFFP have undergone investigations to determine its aetiology.  
 
Amongst those with LFFP, there is minimal potential for the patient’s native facial muscles to regain 
meaningful movement.  As a result, referral to a specialised facial palsy centre should be made.  
Here, a multidisciplinary team (MDT) consisting of surgeons, facial physiotherapists and 
psychologists can plan an optimal treatment strategy.  The objectives are to achieve ocular 
protection, restore nostril opening and restore resting and, where possible, dynamic facial 
symmetry.  A myriad of options exist and it is essential that these patients are given access to review 
in these specialised MDTs. 
 
Post-paralytic facial palsy: 
A potential complication from the spontaneous neural regeneration that occurs following an insult 
to the facial nerve is PPFP.  This typically comprises synkinesis (the development of unwanted facial 
movements), hypertonia (persistent tightness of the facial muscles), and hyperkinesis (exaggerated 
movements).  All can have a significant impact upon facial symmetry and confer significant 
psychological morbidity. 
 
As a result, referral to secondary care is indicated.  Facial physiotherapy plays an important role in 
managing these challenging cases and treatment with botulinum toxin to weaken the overactive 
muscles can carry significant benefit [6].  Surgical options also exist that can be targeted at areas 
that may benefit from a more permanent solution. 
 
Where to refer: 
Currently no standardised referral pathways exist that ensure patients with facial palsy are seen 
within an appropriate dedicated facial palsy service.  A recent patient survey conducted by Facial 
Palsy UK (FPUK) Charity identified that over 50% of patients with facial palsy referred to secondary 
care were not sent to a service that was able to manage their case and required subsequent referral 
onwards [7].  This is likely a result of the patient not being referred to a dedicated facial palsy 
service.  FPUK is in the process of developing a list of recognised facial palsy services across the 
country to aid primary care physicians in selecting an appropriate location to refer patients onto 
(www.facialpalsy.org.uk).   
 
Facial palsy services 
A comprehensive facial palsy service should comprise facial physiotherapists, psychologists, ENT, 
ophthalmology and reconstructive surgeons within their core team with additional access to 
neurology and neurodiagnostic services.  Currently the onus is on those working within specialised 
facial palsy teams to work with local fundholders to better define and establish clear pathways for 
appropriately referring those with facial palsy to secondary care. 
 
Conclusion: 
Although most patients with facial paralysis have Bell’s palsy, some will require input from teams 
specialised in managing those with facial palsy.  Timely referral to such facilities can improve the 
patient’s long-term outcome by enhancing the function within the individual’s native facial 
musculature.  In those with long-standing facial paralysis, or the sequelae associated with aberrant 
nerve regeneration, a breadth of treatment options exist that can be tailored to each patient 
following review within a specialised facial palsy team. 
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Tables: 
Timeframe Indication Rationale Who to refer to 
Immediately Facial palsy associated with other 
neurological findings, slow-onset 
facial palsy (over >3 days), 
palpable pre-auricular mass, 
systemic constitutional symptoms, 
bilateral facial palsy   
Alternative aetiology to Bell’s 
palsy likely.  Needs early 
additional investigations. 
ENT/neurology 
depending on 
distribution of 
symptoms and 
signs 
Immediately Persistent dry eye, corneal 
irritation, corneal ulceration 
Requires urgent 
ophthalmology input to 
restore corneal protection 
Ophthalmology 
within 
comprehensive 
facial palsy service 
3 weeks after onset No improvement in facial 
movements 
Need to exclude alternative 
aetiology.   
Comprehensive 
facial palsy service 
(ENT surgery) 
3 months after onset Incomplete resolution of facial 
palsy 
Need to exclude alternative 
aetiology. 
May benefit from early 
surgical and non-surgical 
interventions to improve 
short and long-term 
outcome. 
 
Comprehensive 
facial palsy service 
(Plastic surgery) 
 
Table 1.  Guidance on when and why to refer patients with acute flaccid facial paralysis. 
